The Evolution of β-Blockers in Coronary Artery Disease and Heart Failure (Part 1/5)

Heart, Artery and Coronary DiseasesHeart Failure

From ACE Inhibitors/ARBs to ARNIs in Coronary Artery Disease and Heart Failure (Part 2/5)

J Am Coll Cardiol.

Leong DP, McMurray JJV, Joseph PG, Yusuf S

doi: 10.1016/j.jacc.2019.04.068.

Cardiovascular Risk and DiseasesHeart, Artery and Coronary Diseases

Association of Coronary Artery Calcium in Adults Aged 32 to 46 Years With Incident Coronary Heart Disease and Death.

JAMA Cardiol.

Carr JJ, Jacobs DR Jr, Terry JG, Shay CM, Sidney S, Liu K, Schreiner PJ, Lewis CE, Shikany JM, Reis JP, Goff DC Jr

doi: 10.1001/jamacardio.

RECOMMENDED

Heart, Artery and Coronary DiseasesHeart Failure

Retinal microvascular dysfunction in patients with coronary artery disease with and without heart failure: a continuum?

Eur J Heart Fail.

Barthelmes J, Nägele MP, Cantatore S, Novruzov E, Ludovici V, von Eckardstein A, Frank M, Ruschitzka F, Sudano I, Flammer AJ

doi: 10.1002/ejhf.1537.

Heart Failure

The role of ventricular-arterial coupling in cardiac disease and heart failure: assessment, clinical implications and therapeutic interventions. A consensus document of the European Society of Cardiology Working Group on Aorta & Peripheral Vascular Diseases, European Association of Cardiovascular Imaging, and Heart Failure Association

Eur J Heart Fail.

Ikonomidis I, Aboyans V, Blacher J, Brodmann M, Brutsaert DL, Chirinos JA, De Carlo M, Delgado V, Lancellotti P, Lekakis J, Mohty D, Nihoyannopoulos P, Parissis J, Rizzoni D, Ruschitzka F, Seferovic P, Stabile E, Tousoulis D, Vinereanu D, Vlachopoulos C, Vlastos D, Xaplanteris P, Zimlichman R, Metra M

doi: 10.1002/ejhf.

Heart, Artery and Coronary DiseasesTherapy and Intervention

Mortality after coronary artery bypass grafting versus percutaneous coronary intervention with stenting for coronary artery disease: a pooled analysis of individual patient data

Lancet.

Head SJ, Milojevic M, Daemen J, Ahn JM, Boersma E, Christiansen EH, Domanski MJ, Farkouh ME, Flather M, Fuster V, Hlatky MA, Holm NR, Hueb WA, Kamalesh M, Kim YH, Mäkikallio T, Mohr FW, Papageorgiou G, Park SJ, Rodriguez AE, Sabik JF 3rd, Stables RH, Stone GW, Serruys PW, Kappetein AP

doi: 10.1016/S0140-6736

RECOMMENDED

Heart Failure

Rivaroxaban in Patients with Heart Failure, Sinus Rhythm, and Coronary Disease

N Engl J Med.

Zannad F, Anker SD, Byra WM, Cleland JGF, Fu M, Gheorghiade M, Lam CSP, Mehra MR, Neaton JD, Nessel CC, Spiro TE, van Veldhuisen DJ, Greenberg B; COMMANDER HF Investigators

doi: 10.1056/NEJMoa1808848.

Heart, Artery and Coronary Diseases

β-blockers, calcium antagonists, and mortality in stable coronary artery disease: an international cohort study

Eur Heart J.

Sorbets E, Steg PG, Young R, Danchin N, Greenlaw N, Ford I, Tendera M, Ferrari R, Merkely B, Parkhomenko A, Reid C, Tardif JC, Fox KM

doi: 10.1093/eurheartj/

Cardiac Arrest or DeathHeart FailureTherapy and Intervention

Sudden Cardiac Death in Patients with Ischemic Heart Failure Undergoing Coronary Artery Bypass Grafting: Results from the Surgical Treatment for Ischemic Heart Failure (STICH) Randomized Clinical Trial.

Circulation.

Rao MP, Al-Khatib SM, Pokorney S, She L, Romanov A, Nicolau JC, Lee KL, Carson PE, Selzman CH, Stepinska J, Cleland JG, Tungsubutra W, Desvigne-Nickens PM, Sueta C, Siepe M, Lang IM, Feldman AM, Yii M, Rouleau JL, Velazquez EJ

doi: 10.1161/CIRCULATIONAHA.

Heart, Artery and Coronary DiseasesTherapy and Intervention

Impact of Coronary Artery Disease on 30-Day and 1-Year Mortality in Patients Undergoing Transcatheter Aortic Valve Replacement: A Meta-Analysis

J Am Heart Assoc.

Sankaramangalam K, Banerjee K, Kandregula K, Mohananey D, Parashar A, Jones BM, Jobanputra Y, Mick S, Krishnaswamy A, Svensson LG, Kapadia SR

doi: 10.1161/

Related content